Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Stomach Neoplasms × Immune Checkpoint Inhibitors × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5 Squamous Cell Carcinoma of Head and Neck 2 Solid Cancers 2 Melanoma 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcopenia 1 SCLC 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Immune-Related Adverse Events 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Biliary Tract Neoplasms 1

Interventions

Oxaliplatin 16 Fluorouracil 15 pembrolizumab 11 Capecitabine 11 Leucovorin 10 Nivolumab 9 Trastuzumab 6 Specimen Handling 6 Cisplatin 6 trastuzumab deruxtecan 5 Paclitaxel 4 Magnetic Resonance Spectroscopy 4 Carboplatin 4 Biopsy 4 zimberelimab 3 Folfox protocol 3 Drug Therapy 3 Docetaxel 3 Bevacizumab 3 zanidatamab 2 tucatinib 2 trifluridine tipiracil drug combination 2 durvalumab 2 XELOX 2 zolbetuximab 1 toripalimab 1 tislelizumab 1 talazoparib 1 ropidoxuridine 1 regorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡